In previous studies, CDK4 was reported to play a significant role in promoting the pathogenesis of tumors including oral squamous cell carcinoma [1], pancreatic endocrine tumors [2], lung cancer [3, 4], nasopharyngeal carcinoma [5–7], and other tumors [8–10]. This evidence concerns the gene CDK4 and nasopharyngeal carcinoma.